A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Daily Administrations of the GLP-1 Analogue ROSE-010 on Appetite and Food Intake in Overweight and Obese Subjects
Latest Information Update: 07 Oct 2024
At a glance
- Drugs LY 307161 (Primary)
- Indications Obesity; Overweight
- Focus Therapeutic Use
- Sponsors Rose Pharma
- 07 Oct 2024 New trial record